RN7SL386P

Across TCGA pan-cancer cohorts, RN7SL386P RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated RN7SL386P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RN7SL386P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL386P expression acts as an unfavorable survival marker, although some lineages such as OV and HNSC show a favorable association.

BLCA, LIHC, and KICH are the cancer types where RN7SL386P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	IV	0.196	0.602	<.001	120	view →
LIHC	OS	Tertile	All	0.059	0.775	<.001	81	view →
KICH	OS	Tertile	II,III,IV	0.070	0.828	<.001	63	view →
TGCT	DFS	Tertile	All	0.461	0.846	<.001	54	view →
ESCA	OS	Tertile	All	0.535	0.750	.002	39	view →
CHOL	OS	Tertile	II,III,IV	0.087	0.833	<.001	36	view →
PAAD	DFS	Tertile	III,IV	0.118	0.734	.014	27	view →
COAD	OS	Tertile	II,III,IV	0.187	0.608	.011	21	view →
SKCM	OS	Tertile	IV	0.415	0.861	.014	9	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
SARC	OS	Tertile	All	0.338	0.733	.026	9	view →
OV	OS	Tertile	III,IV	0.923	0.676	.042	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

RN7SL386P–BLCA (OS)

Open the BLCA breakdown →